Medical cannabis is a highly cost-effective treatment for individuals with moderate post-traumatic stress disorder (PTSD), according to a new study.
The US Food and Drug Administration (FDA) has finally approved a Phase 2 clinical trial into cannabis in treatment of post-traumatic stress disorder (PTSD), three years after being put on hold.
Last week, Ukraine’s law officially legalising medical cannabis came into effect, eight months after initially being passed. Despite the positive
A commitment to supporting the UK’s military community and veterans – known as the Armed Forces Covenant – has been
In an update to its clinical guidelines, the US Department of Veterans Affairs (VA) has stated its opposition to the
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
